Redox Report

Redox Report is a multidisciplinary open access journal published by Taylor & Francis that focuses on the role of free radicals and redox processes in human pathology and the human environment, founded in 1994 and edited by Paul Witting, with a 2025 Journal Impact Factor of 6.9《氧化还原报告》（Redox Report）是（Taylor & Francis）出版的多学科开放获取期刊，聚焦自由基与氧化还原过程在人类病理及人类环境中的作用，1994 年创刊，主编为（Paul Witting），2025 年影响因子为 6.9。

Scope

• The journal focuses on the role of free radicals and redox processes该刊聚焦自由基与氧化还原过程的作用。
• It accepts papers related to the human environment and human pathology through topics such as oxidative stress, activated oxygen and peroxidative and redox processes期刊通过氧化应激、活化氧以及过氧化与氧化还原过程等主题，接收与人类环境和人类病理相关的论文。
• Relevant papers on the animal and plant environment, biology and pathology are also included与动物和植物环境、生物学及病理学相关的论文亦在其列。
• Emphasis is placed on methodological and intellectual advances underpinned by new data期刊强调以新数据为支撑的方法学与思想上的进展。
• It publishes original research articles and review articles期刊发表原创研究论文与综述文章。
• The journal is aimed at biochemists, cell biologists, chemists, clinicians and pathophysiologists concerned with free radicals读者对象为关注自由基的生物化学家、细胞生物学家、化学家、临床医师与病理生理学家。

History

• The journal was founded in 1994 with the subtitle Communications in Free Radical Research该刊 1994 年创办，副标题为（Communications in Free Radical Research）。
• It was originally published from Edinburgh and New York by Churchill Livingstone创刊时由（Churchill Livingstone）在爱丁堡与纽约出版。
• Publication later passed through Maney Publishing and, from 2016, has been handled by Taylor & Francis from Abingdon in the United Kingdom出版方其后经（Maney Publishing），自 2016 年起由（Taylor & Francis）在英国阿宾登出版。
• It is a fully open access journal published under print ISSN 1351-0002 and electronic ISSN 1743-2928, with an article processing charge of 1625 pounds该刊为完全开放获取期刊，印刷 ISSN 为 1351-0002，电子 ISSN 为 1743-2928，文章处理费为 1625 英镑。
• It is indexed in the Science Citation Index Expanded, Scopus, PubMed, MEDLINE and the Directory of Open Access Journals, and its Journal Impact Factor moved from 4.412 in 2021 through 5.696 in 2022 and 7.4 in 2024 to 6.9 in 2025该刊被（Science Citation Index Expanded）、（Scopus）、（PubMed）、（MEDLINE）与（Directory of Open Access Journals）收录，影响因子由 2021 年的 4.412 经 2022 年的 5.696 与 2024 年的 7.4 变为 2025 年的 6.9。

Editors

• The Editor is Paul Witting, associate professor of pathology at the University of Sydney in Australia主编为（Paul Witting），是澳大利亚（University of Sydney）的病理学副教授。
• The journal operates a single anonymised peer review policy该刊实行单匿名同行评审政策。
• Average review time is about 27 weeks, and the journal is checked for plagiarism as part of its open access policies平均审稿时长约 27 周，期刊按开放获取政策进行重复率检查。
• About 89.7 percent of published items are original research rather than reviews已发表内容中约 89.7 百分比为原创研究而非综述。
• The journal reports 379 thousand annual downloads and views期刊年度下载与浏览量约 37.9 万次。